The essential role of a multidisciplinary approach in inflammatory bowel diseases: combined medical-surgical treatment in complex perianal fistulas in CD
J Geldof, N Iqbal, J Warusavitarne… - Clinics in Colon and …, 2022 - thieme-connect.com
Perianal fistulizing Crohn's disease (PFCD) represents a challenging and complex disease
phenotype. Patients typically suffer a more severe disease course than those without …
phenotype. Patients typically suffer a more severe disease course than those without …
Surgical vs Medical Management of Symptomatic Anal Fistulas in Patients with Crohn's Disease
M Obi, AL Lightner - Difficult Decisions in Colorectal Surgery, 2024 - Springer
One of the most common presentations of Crohn's Disease (CD) is the formation of perianal
fistulas which affects anywhere from 5–40% of CD patients worldwide, and it can be the …
fistulas which affects anywhere from 5–40% of CD patients worldwide, and it can be the …
Certolizumab Pegol in Crohn's Disease Management: A Multicentric Brazilian Observational Study
Introduction and Objectives Certolizumab Pegol (CZP) is an anti-TNF agent approved in
Brazil for Crohn's disease (CD). There is a lack of data in Brazil and Latin America detailing …
Brazil for Crohn's disease (CD). There is a lack of data in Brazil and Latin America detailing …
[HTML][HTML] The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel …
J Geldof, N Iqbal, J Warusavitarne… - Clinics in Colon and …, 2022 - ncbi.nlm.nih.gov
Perianal fistulizing Crohn's disease (PFCD) represents a challenging and complex disease
phenotype. Patients typically suffer a more severe disease course than those without …
phenotype. Patients typically suffer a more severe disease course than those without …
Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
OV Knyazev, AV Kagramanova… - Terapevticheskii …, 2018 - ter-arkhiv.ru
Aim. To assess the efficacy and tolerance of certolizumab pegol (CP) in patients with
Crohn's disease (CD) treated in the Department of inflammatory bowel diseases of the AS …
Crohn's disease (CD) treated in the Department of inflammatory bowel diseases of the AS …
Эффективность и переносимость цертолизумаба пэгола при болезни Крона в реальной клинической практике
ОВ Князев, АВ Каграманова, АА Лищинская… - Терапевтический …, 2018 - cyberleninka.ru
Цель исследования-оценить эффективность и переносимость цертолизумаба пэгола
(ЦЗП) у пациентов с болезнью Крона (БК), проходивших лечение в отделении …
(ЦЗП) у пациентов с болезнью Крона (БК), проходивших лечение в отделении …